• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Fe3O4 nanoclusters highly dispersed on a porous graphene support as an additive for improving the hydrogen storage properties of LiBH4?
  Guang Xu,Wei Zhang,Ying Zhang,Xiaoxia Zhao,Ping Wen,Di Ma RSC Adv., 2018,8, 19353-19361
• 5. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Methoxybenzoic acids and derivatives

Latest Research Insights on 3-Cyano-4-methoxybenzoic acid (CAS: 117738-82-6)

3-Cyano-4-methoxybenzoic acid (CAS: 117738-82-6) is a key intermediate in the synthesis of various pharmaceuticals and bioactive compounds. Recent studies have highlighted its significance in drug discovery, particularly in the development of kinase inhibitors and anti-inflammatory agents. This research brief consolidates the latest findings on its synthetic applications, biological activities, and potential therapeutic uses.

A 2023 study published in the Journal of Medicinal Chemistry explored the role of 3-Cyano-4-methoxybenzoic acid as a precursor in the synthesis of novel Bruton's tyrosine kinase (BTK) inhibitors. The research demonstrated that derivatives of this compound exhibited potent inhibitory activity against BTK, a target for autoimmune diseases and B-cell malignancies. The study emphasized the compound's structural versatility, enabling modifications that enhance binding affinity and selectivity.

Another significant advancement was reported in Bioorganic & Medicinal Chemistry Letters, where researchers utilized 3-Cyano-4-methoxybenzoic acid to develop COX-2 selective inhibitors. The compound's methoxy and cyano functional groups were critical in optimizing the pharmacokinetic properties of the resulting molecules, leading to improved anti-inflammatory efficacy and reduced gastrointestinal toxicity compared to traditional NSAIDs.

Recent patent filings (WO2023056321, 2023) have also highlighted the use of 3-Cyano-4-methoxybenzoic acid in the synthesis of PROTACs (Proteolysis Targeting Chimeras). These bifunctional molecules leverage the compound's scaffold to target disease-causing proteins for degradation, offering a promising strategy for cancer therapy. The patent data suggest that the compound's chemical stability and compatibility with linker technologies make it a valuable building block in this emerging field.

Analytical chemistry studies have focused on improving the purification and characterization of 3-Cyano-4-methoxybenzoic acid. A 2024 paper in Analytical Chemistry presented a novel HPLC method for quantifying trace impurities in industrial-scale production, addressing previous challenges in quality control for pharmaceutical applications.

Ongoing research at several academic institutions is investigating the compound's potential in neurodegenerative diseases. Preliminary data suggest that certain derivatives may modulate α-synuclein aggregation, a pathological hallmark of Parkinson's disease. While still in early stages, these findings could open new avenues for therapeutic development.

In conclusion, 3-Cyano-4-methoxybenzoic acid (117738-82-6) continues to demonstrate significant value in medicinal chemistry. Its applications span from traditional small molecule drugs to innovative therapeutic modalities like PROTACs. Future research directions likely include further exploration of its structure-activity relationships and expansion into additional therapeutic areas.

• 263387-97-9(1-Naphthalenecarboxylic acid, 3-cyano-2-methoxy-)
• 102362-00-5(4-Cyano-3-methoxybenzoic acid)
• 89469-52-3(4-Cyano-2-methoxybenzoic acid)
• 258273-32-4(3-Cyano-4-ethoxybenzoic acid)
• 174261-09-7(Benzoic acid, 5-cyano-2,4-dimethoxy-)
• 946007-61-0(4-(Benzyloxy)-3-cyanobenzoic acid)
• 403825-99-0(4-((2-cyanophenoxy)methyl)benzoic acid)
• 25978-74-9(Methyl 3-cyano-4-methoxybenzoate)
• 838873-20-4(2-Naphthalenecarboxylic acid, 7-cyano-6-methoxy-)
• 70829-28-6(3-Cyano-4-hydroxybenzoic acid)